QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
−Removed: Financial market risks related to interest rates, equity investments, foreign currency exchange rates and inflation are described in the Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations of ImmunityBio, Inc.
−Removed: filed as Exhibit 99.3 to our Current Report on Form 8-K filed with the SEC on April 22, 2021, there have been no material changes to the financial market risks described at December 31, 2020.
+Added: Financial market risks related to interest rates, equity investments, foreign currency exchange rates and inflation are described in the Management’s Discussion and Analysis of Financial Condition and Results of Operations of ImmunityBio, Inc.
+Added: filed as Exhibit 99.3 to our Current Report on Form 8-K/A filed with the SEC on April 22, 2021.
+Added: There have been no material changes to such financial market risks as of the date of this Quarterly Report on Form 10-Q.
We do not currently anticipate any other near-term changes in the nature of our financial market risk exposures or in management’s objectives and strategies with respect to managing such exposures.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.